• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. PERCEVAL PLUS SUTURELESS HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. PERCEVAL PLUS SUTURELESS HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-S
Device Problem Difficult to Open or Close (2921)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 06/17/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, a perceval plus valve size s (pvf-s) was implanted as part of an aortic valve replacement procedure.After the implant, the tee showed severe perivalvular leak (pvl).The correct position of the perceval plus valve was confirmed with the post implant tee.The perceval valve was consequently explanted intraoperatively.The annulus was re-examined for any possible leftover calcium deposits and was re-sized.A new perceval plus valve pvf-s was ultimately implanted.The tee confirmed a good functionality of the new valve implanted.Upon visual inspection of the affected valve, a structural problem was identified.The patient¿s postoperative course was complicated by mitral valve regurgitation, that was not directly linked with the perceval valve implantation.On (b)(6) 2021, a perceval plus valve size s (pvf-s) was implanted as part of an aortic valve replacement procedure.After the implant, the tee showed severe perivalvular leak (pvl).The correct position of the perceval plus valve was confirmed with the post implant tee.The perceval valve was consequently explanted intraoperatively.The annulus was re-examined for any possible leftover calcium deposits and was re-sized.A new perceval plus valve pvf-s was ultimately implanted.The tee confirmed a good functionality of the new valve implanted.Upon visual inspection of the affected valve, a structural problem was identified.The patient¿s postoperative course was complicated by mitral valve regurgitation, that was not directly linked with the perceval valve implantation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli 13040
IT  13040
MDR Report Key12181327
MDR Text Key262028751
Report Number1718850-2021-01128
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 07/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date03/22/2022
Device Model NumberPVF-S
Device Catalogue NumberPVF-S
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date06/17/2021
Event Location Hospital
Date Report to Manufacturer07/16/2021
Date Manufacturer Received06/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-